Search results for "TC"

showing 10 items of 9993 documents

Endonasal Approach for Nasal and Paranasal Sinus Tumor Removal

2001

Patients with benign (53) and malignant (22) tumors of the nose and paranasal sinuses were treated for tumor removal via an endonasal approach. Patient selection was based on tumor location (centrally) rather than histology. Tumors attainable by the endonasal approach were located in the nasal cavity, the ethmoid sinus, the sphenoid sinus and the medial wall of the maxillary sinus. Endonasal microscopic techniques including endonasal orbital decompression and endonasal closure of CSF-leaks were combined with surgical navigation tools in selected cases. Surgical trauma and morbidity could be minimized without compromising radicality of tumor removal. Postoperative hospitalization was compara…

AdultMaleNasal cavitymedicine.medical_specialtyAdolescentMaxillary sinusNose NeoplasmsEthmoid sinusParanasal Sinusesotorhinolaryngologic diseasesmedicineHumansChildSinus (anatomy)NoseAgedRetrospective StudiesAged 80 and overIntraoperative Carebusiness.industryPatient SelectionParanasal Sinus TumorInfantEndoscopyMiddle AgedSurgeryRadiographyTreatment OutcomeParanasal sinusesmedicine.anatomical_structureOtorhinolaryngologyChild PreschoolFemaleTumor removalNeoplasm Recurrence LocalbusinessORL
researchProduct

Surgical treatment of choanal atresia with transnasal endoscopic approach with stentless single side-hinged flap technique: 5 year retrospective anal…

2017

Introdução: A atresia de coanas é uma malformação congênita rara da cavidade nasal caracterizada pela obliteração completa da coana posterior. Nos 67% dos casos a atresia coanal é unilateral, acometendo principalmente (71%) a cavidade nasal direita. Diferentemente da forma unilateral, a atresia coanal bilateral é uma condição com risco de vida, frequentemente associada a angústia respiratória com alimentação e cianose intermitente exacerbada pelo choro. O tratamento cirúrgico permanece como a única opção terapêutica. Objetivo: Relatar a nossa experiência no uso de uma abordagem endoscópica transnasal com a técnica de retalho articulado de um lado só sem colocação de stent para o tratamento …

AdultMaleNasal cavitymedicine.medical_specialtyAdolescentmedicine.medical_treatmentAtresia de coanaChoanal atresiaRestenoseChoanal atresia; Endoscopic nasal surgery; Re-stenosis; Otorhinolaryngology2734 Pathology and Forensic MedicineTransanal Endoscopic SurgeryYoung Adult03 medical and health sciences0302 clinical medicineRestenosismedicineotorhinolaryngologic diseasesHumansChild030223 otorhinolaryngologyRetrospective StudiesTransanal Endoscopic SurgeryRespiratory distressbusiness.industryOtorhinolaryngology2734 Pathology and Forensic MedicineChoanal atresiaRe-stenosisStentRetrospective cohort studyMiddle Agedmedicine.diseaselcsh:Otorhinolaryngologylcsh:RF1-547SurgeryBilateral choanal atresiaTreatment Outcomemedicine.anatomical_structureRe-stenosiEndoscopic nasal surgeryOtorhinolaryngologyCirurgia nasal endoscópicaFemaleTomography X-Ray Computedbusiness030217 neurology & neurosurgery
researchProduct

The Use of Acoustic Rhinometry in Predicting Outcomes after Sinonasal Surgery

2000

Today's healthcare environment demands objective assessment of surgical outcomes. The recent otolaryngologic literature has established acoustic rhinometry (AR) as a valid instrument to objectively document nasal patency. The purpose of this article is to evaluate the utility of AR in predicting outcomes after sinonasal surgery. All patients scheduled for sinonasal surgery at the Tulane University and University of Mainz Departments of Otolaryngology between 10/1/98 and 12/15/98 were enrolled. All subjects underwent AR and completed a sinonasal outcome survey (SNOT-20) one day before and two months after their surgical procedure. Thirty-one patients were enrolled. The SNOT-20 raw scores im…

AdultMaleNasal cavitymedicine.medical_specialtyManometryObjective assessment03 medical and health sciencesSubjective improvement0302 clinical medicineAcoustic rhinometryPredictive Value of TestsParanasal SinusesmedicineHumansRaw score030223 otorhinolaryngologybusiness.industryMean valueSurgeryTreatment Outcomemedicine.anatomical_structureOtorhinolaryngologyOtorhinolaryngology030220 oncology & carcinogenesisFemalebusinessAmerican Journal of Rhinology
researchProduct

Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up.

1998

Acute infection with hepatitis C virus (HCV) develops into a chronic hepatitis in about 50-70% of patients. Treatment of these patients with interferon-alpha (IFN-alpha) results in a sustained long-term response in only 15-20% but causes numerous unwanted side-effects in a higher percentage of patients. The aim of our study was to define host or viral parameters that would allow identification of responders and non-responders to IFN-alpha prior to the onset of treatment. We studied a group of 87 patients suffering from chronic hepatitis C who were treated with IFN-alpha. After long-term follow-up, 18 patients (21%) showed a sustained response to IFN-alpha therapy (normalization of serum tra…

AdultMaleNecrosisGenotypeHepatitis C virusAlpha interferonInflammationHepacivirusmedicine.disease_causeAntiviral AgentsFibrosisVirologyGenotypemedicineHumansViremiaHepatologymedicine.diagnostic_testbusiness.industryTumor Necrosis Factor-alphaInterferon-alphaHLA-DR AntigensHepatitis C ChronicMiddle AgedViral Loadmedicine.diseaseInfectious DiseasesTreatment OutcomeLiver biopsyImmunologyRNA ViralFemalemedicine.symptombusinessViral hepatitisFollow-Up StudiesJournal of viral hepatitis
researchProduct

Comparing extracorporeal shock wave lithotripsy and ureteroscopy laser lithotripsy for treatment of urinary stones smaller than 2 cm: a cost-utility …

2021

[EN] Purpose To analyze the efficiency and cost-utility profile of ureteroscopy versus shock wave lithotripsy for treatment of reno-ureteral stones smaller than 2 cm. Methods Patients treated for urinary stones smaller than 2 cm were included in this study (n = 750) and divided into two groups based on technique of treatment. To assess the cost-utility profile a sample of 48 patients (50% of each group) was evaluated. Quality of life survey (Euroqol 5QD-3L) before-after treatment was applied, Markov model was designed to calculate quality of life in each status of the patients (stone or stone-free with and without double-J stent) and to estimate the incremental cost-utility. Monte carlo sim…

AdultMaleNephrologyQuality of lifemedicine.medical_specialtyUreteral CalculiCost-Benefit AnalysisUrologymedicine.medical_treatment030232 urology & nephrologyUrologySubgroup analysisLithotripsyUrinary calculiKidney Calculi03 medical and health sciences0302 clinical medicineInternal medicineLithotripsymedicineUreteroscopyHumansUrologiaQuality-adjusted life yearsUreteroscopyAgedmedicine.diagnostic_testbusiness.industryStentMiddle AgedLithotripsy LaserLaser lithotripsyExtracorporeal shock wave lithotripsyQuality-adjusted life yearTreatment OutcomeSpain030220 oncology & carcinogenesisFemalebusiness
researchProduct

Short-Term Functional and Oncologic Outcomes of Nephron-Sparing Surgery for Renal Tumours ≥7cm

2011

Abstract Background Nephron-sparing surgery (NSS) for renal tumours preserves renal function and has become the standard approach for small renal tumours. Little is known about perioperative and oncologic outcomes of patients following NSS in renal tumours ≥7cm in the presence of a healthy contralateral kidney. Objective To analyse oncologic outcomes and perioperative morbidity in patients treated by NSS for renal tumours ≥7cm. Design, setting, and participants In total, 5767 patients were treated for renal tumours at two institutions from 1984 to 2009. In 91 patients, elective NSS was performed for renal tumours ≥7cm. Measurements Complication rates were assessed in detail and stratified u…

AdultMaleNephrologymedicine.medical_specialtyTime FactorsUrologymedicine.medical_treatmentKaplan-Meier EstimateNephrectomyRisk AssessmentDisease-Free SurvivalRisk FactorsRenal cell carcinomaGermanyInternal medicinemedicineHumansMinimally Invasive Surgical ProceduresSurvival rateAgedNeoplasm StagingRetrospective StudiesAged 80 and overUnivariate analysisbusiness.industryPatient SelectionPerioperativeMiddle Agedmedicine.diseaseKidney NeoplasmsNephrectomyTumor BurdenSurgerySurvival RateLogistic ModelsTreatment OutcomeFemalebusinessKidney cancerKidney diseaseEuropean Urology
researchProduct

Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study

2007

Objectives: To investigate efficacy, safety, and impact on quality of sleep of desmopressin in the treatment of nocturia. Methods: Adults aged >= 18 yr with nocturia (>= 2 voids/night) received desmopressin tablets (0.1, 0.2, or 0.4 mg) during a 3-wk dose-titration period. Patients should show sufficient response during the dose-titration period (>= 20% reduction in nocturnal diuresis) and a return of nocturnal diuresis to >= 80% of baseline levels during washout. Eligible patients then entered a 3-wk double-blind treatment period and received either desmopressin or placebo. Results: 127 patients were randomised to either desmopressin (n = 61) or placebo (n = 66). Twenty (33%) desmopressin-…

AdultMaleNephrologymedicine.medical_specialtyUrologyPlacebo-controlled studyAdministration OralDiuresisPlaceboDouble-Blind MethodInternal medicinemedicineHumansNocturiaDeamino Arginine VasopressinDesmopressinAdverse effectAgedAged 80 and overDose-Response Relationship Drugbusiness.industryAntidiuretic AgentsMiddle AgedSurgeryUrodynamicsTreatment OutcomeAnesthesiaFemaleNocturiamedicine.symptomSleepbusinesshormones hormone substitutes and hormone antagonistsFollow-Up Studiesmedicine.drugAntidiureticEuropean Urology
researchProduct

Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes

2007

OBJECTIVE To analyse the functional and oncological outcomes of surgical treatment of bilateral synchronous sporadic renal cell carcinoma (RCC). PATIENTS AND METHODS Between 1969 and 2006, 57 patients with bilateral synchronous sporadic RCC were identified from our kidney database. The mean (range) follow-up was 4.8 (0.1–23.8) years; 28 patients (49%) had radical nephrectomy (RN) and contralateral nephron-sparing surgery (NSS), and 22 (39%) had bilateral NSS. The oncological outcome and long-term renal function were analysed. RESULTS After excluding four patients (7%) with bilateral benign renal tumours, six (11%) with metastatic bilateral RCC and three (5%) who had bilateral RN, the cancer…

AdultMaleNephrologymedicine.medical_specialtyUrologymedicine.medical_treatmentRenal functionurologic and male genital diseasesNephrectomyNeoplasms Multiple PrimaryRenal cell carcinomaInternal medicineCarcinomaHumansMedicineCarcinoma Renal CellDialysisAgedNeoplasm StagingAged 80 and overbusiness.industryNephronsMiddle AgedPrognosismedicine.diseaseSurvival AnalysisKidney NeoplasmsNephrectomySurgeryTreatment OutcomeFemalebusinessKidney cancerFollow-Up StudiesKidney diseaseBJU International
researchProduct

Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

2017

<b><i>Background/Aim:</i></b> Individual components of the metabolic syndrome (MS) such as obesity or diabetes mellitus impair the prognosis of patients with hepatocellular carcinoma (HCC) following curative treatment approaches or transarterial therapies. The aim of this retrospective study was to assess the impact of these factors on the overall survival (OS) of patients with advanced HCC treated with sorafenib. <b><i>Methods:</i></b> Univariate and multivariate analyses were performed to assess the impact of individual components of the MS on the OS of 152 consecutive patients with advanced HCC treated with sorafenib. <b><i>Resu…

AdultMaleNiacinamideOncologySorafenibmedicine.medical_specialtyCarcinoma HepatocellularAntineoplastic AgentsYoung Adult03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinemedicineHumansSurvival analysisAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overMetabolic Syndromebusiness.industryProportional hazards modelPhenylurea CompoundsLiver NeoplasmsHazard ratioGastroenterologyGeneral MedicineMiddle AgedSorafenibPrognosismedicine.diseaseSurvival Analysisdigestive system diseasesTreatment OutcomeDiabetes Mellitus Type 2030220 oncology & carcinogenesisHepatocellular carcinomaMultivariate AnalysisFemale030211 gastroenterology & hepatologyMetabolic syndromebusinessDyslipidemiamedicine.drugDigestive Diseases
researchProduct

Dual-Energy CT Material Density Iodine Quantification for Distinguishing Vascular From Nonvascular Renal Lesions: Normalization Reduces Intermanufact…

2019

OBJECTIVE. The purpose of this study was to determine whether a single, uniform normalized iodine threshold reduces variability and enables reliable differentiation between vascular and nonvascular renal lesions independent of the dual-energy CT (DECT) platform used. MATERIALS AND METHODS. In this retrospective, HIPAA-compliant, institutional review board-approved study, 247 patients (156 men, 91 women; mean age ± SD, 67 ± 12 years old) with 263 renal lesions (193 nonvascular, 70 vascular) underwent unenhanced single- energy and contrast-enhanced DECT scans. One hundred and six nonvascular and 38 vascular lesions were scanned on two dual-source DECT (dsDECT) scanners, and 87 nonvascular and…

AdultMaleNormalization (statistics)chemistry.chemical_elementIodinedual-energy CTrapid-kilovoltage switching030218 nuclear medicine & medical imagingDiagnosis DifferentialRadiography Dual-Energy Scanned ProjectionYoung Adult03 medical and health sciences0302 clinical medicineHumansMedicineDual sourceRadiology Nuclear Medicine and imagingAgedRetrospective StudiesAged 80 and overvariabilitybusiness.industryGeneral MedicineMaterial densityMiddle Agedrenal lesionKidney Neoplasmschemistry030220 oncology & carcinogenesisdual sourceFemaleDual energy ctTomography X-Ray ComputedbusinessNuclear medicineIodineAmerican Journal of Roentgenology
researchProduct